CSF2 and neoplasm: Evidence was obtained that arming MV with GM-CSF improves the attraction of immune cells to a tumor and enhances the induction of a tumor-specific immune response.156 It is highly likely that the encouraging results obtained using the murine model can be translated into successful clinical trials benefiting cancer patients.